|
Diabetes Care, Vol 23, Issue 5 650-657, Copyright © 2000 by American Diabetes Association
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance
H Larsson and B Ahren
Department of Medicine, Lund University, Malmo, Sweden. hillevi.larsson@medfork.mas.lu.se
OBJECTIVE: To characterize in detail the association between insulin
sensitivity and islet function in relation to glucose tolerance in
nondiabetic subjects. RESEARCH DESIGN AND METHODS: The study included 108
postmenopausal women, aged 57-59 years, with normal glucose tolerance (NGT)
or impaired glucose tolerance (IGT) and measured glucose tolerance (World
Health Organization, 75 g glucose), insulin sensitivity
(euglycemic-hyperinsulinemic clamp), and islet function (the 2-5 min
insulin responses [AIR] and glucagon [AGR] responses to 5 g intravenous
arginine at fasting, 14 and >25 mmol/l glucose levels). The product of
insulin sensitivity and secretion was calculated (disposition index [DI])
and used to study the relationship between the two parameters. RESULTS:
Insulin sensitivity and insulin secretion were highly inversely correlated
in a hyperbolic manner (r > 0.64, P < 0.001) in women with NGT (n =
71). Women with IGT (n = 37) had reduced insulin sensitivity compared with
women with NGT (P = 0.011). The AIRs were not appropriately increased in
relation to the reduced insulin sensitivity in the IGT women, demonstrated
as reduced DI in IGT compared with NGT (P < 0.001). Further, women with
IGT had an increased AGR (P < 0.001) and a reduced glucose inhibition of
glucagon secretion (slopeAGR, P = 0.014) compared with women with NGT. In a
multivariate regression model including all of the 108 women, 2-h glucose
was independently determined by the DI, the AGR, and the slopeAGR (r =
0.63, P < 0.001). CONCLUSIONS: We have shown that both the individual
ability to adapt insulin secretion to the ambient insulin sensitivity and
the level of glucagon secretion are important parameters for maintenance of
NGT. Therefore, islet dysfunction in IGT involves low insulin and high
glucagon secretion, which present potential targets for correcting impaired
glycemia.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Quesada, E. Tuduri, C. Ripoll, and A. Nadal
Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose homeostasis and diabetes
J. Endocrinol.,
October 1, 2008;
199(1):
5 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tsuchiyama, T. Takamura, H. Ando, M. Sakurai, A. Shimizu, K.-i. Kato, S. Kurita, and S. Kaneko
Possible Role of {alpha}-Cell Insulin Resistance in Exaggerated Glucagon Responses to Arginine in Type 2 Diabetes
Diabetes Care,
October 1, 2007;
30(10):
2583 - 2587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakaue, S. Ishimaru, D. Ikeda, Y. Ohtsuka, T. Honda, J.-i. Suzuki, Y. Kawakami, J. Ishii, and M. Nishimura
Estimation of beta-cell function from the data of the oral glucose tolerance test
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1575 - E1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abdul-Ghani and R. A. DeFronzo
Fasting Hyperglycemia Impairs Glucose- But Not Insulin-Mediated Suppression of Glucagon Secretion
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1778 - 1784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Xiang, C. Wang, R. K. Peters, E. Trigo, S. L. Kjos, and T. A. Buchanan
Coordinate Changes in Plasma Glucose and Pancreatic {beta}-Cell Function in Latino Women at High Risk for Type 2 Diabetes.
Diabetes,
April 1, 2006;
55(4):
1074 - 1079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Chang, M. J. Smith, C. J. Bloem, A. T. Galecki, J. B. Halter, and M. A. Supiano
Limitation of the Homeostasis Model Assessment to Predict Insulin Resistance and {beta}-Cell Dysfunction in Older People
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
629 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Del Prato, R. Miccoli, and G. Penno
Review: The importance of effective early phase insulin secretion
The British Journal of Diabetes & Vascular Disease,
July 1, 2005;
5(4):
198 - 202.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Yeckel, S. E. Taksali, J. Dziura, R. Weiss, T. S. Burgert, R. S. Sherwin, W. V. Tamborlane, and S. Caprio
The Normal Glucose Tolerance Continuum in Obese Youth: Evidence for Impairment in {beta}-Cell Function Independent of Insulin Resistance
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
747 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jiang and B. B. Zhang
Glucagon and regulation of glucose metabolism
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E671 - E678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahren and O. Thorsson
Increased Insulin Sensitivity Is Associated with Reduced Insulin and Glucagon Secretion and Increased Insulin Clearance in Man
J. Clin. Endocrinol. Metab.,
March 1, 2003;
88(3):
1264 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Del Prato, P. Marchetti, and R. C. Bonadonna
Phasic Insulin Release and Metabolic Regulation in Type 2 Diabetes
Diabetes,
February 1, 2002;
51(90001):
S109 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahren and H. Larsson
Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal Women
Diabetes,
February 1, 2002;
51(90001):
S202 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|